Free Trial

Bar Harbor Wealth Management Acquires 8,226 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Bar Harbor Wealth Management raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 177,097 shares of the company's stock after buying an additional 8,226 shares during the quarter. Bar Harbor Wealth Management owned approximately 0.07% of Ryan Specialty worth $13,082,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of RYAN. Vanguard Group Inc. lifted its holdings in Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock worth $633,933,000 after buying an additional 529,631 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of Ryan Specialty by 2.5% during the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock valued at $210,651,000 after purchasing an additional 79,976 shares during the last quarter. Blair William & Co. IL lifted its holdings in shares of Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after purchasing an additional 16,540 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after buying an additional 981,505 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Ryan Specialty by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after buying an additional 46,960 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

RYAN has been the topic of a number of research reports. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. UBS Group upped their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Barclays decreased their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Morgan Stanley increased their target price on Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Finally, Royal Bank of Canada lowered their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Ryan Specialty presently has a consensus rating of "Moderate Buy" and an average price target of $75.58.

Read Our Latest Analysis on Ryan Specialty

Insiders Place Their Bets

In other Ryan Specialty news, Director David P. Bolger sold 5,000 shares of the stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the transaction, the director now owns 71,467 shares in the company, valued at $5,059,863.60. This trade represents a 6.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 52.21% of the company's stock.

Ryan Specialty Price Performance

Ryan Specialty stock traded down $0.36 during trading hours on Monday, hitting $65.46. 606,750 shares of the stock were exchanged, compared to its average volume of 993,856. The business's 50-day moving average is $69.06 and its two-hundred day moving average is $68.38. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 12 month low of $52.37 and a 12 month high of $77.16. The stock has a market capitalization of $17.18 billion, a P/E ratio of 94.87, a P/E/G ratio of 1.19 and a beta of 0.70.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. During the same quarter in the prior year, the company earned $0.35 EPS. The firm's quarterly revenue was up 25.0% on a year-over-year basis. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.73%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's payout ratio is presently 141.18%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines